Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)

由 Li, Yan, Li, Ling, De Peng, Yong, Song, Guang Yao, Ye, Shan Dong, Du, Li Ying, Hou, Jia Ning, Ji, Qiu He
發表在 Diabetes Ther (2019)

Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

由 Ji, Li-Nong, Lu, Ju-Ming, Guo, Xiao-Hui, Yang, Wen-Ying, Weng, Jian-Ping, Jia, Wei-Ping, Zou, Da-Jin, Zhou, Zhi-Guang, Yu, De-Min, Liu, Jie, Shan, Zhong-Yan, Yang, Yu-Zhi, Hu, Ren-Ming, Zhu, Da-Long, Yang, Li-Yong, Chen, Li, Zhao, Zhi-Gang, Li, Qi-Fu, Tian, Hao-Ming, Ji, Qiu-He, Liu, Jing, Ge, Jia-Pu, Shi, Li-Xin, Xu, Yan-Cheng
出版 2013